9
The availability of weight loss drugs is about to drop significantly, leaving thousands of Americans without access to more affordable obesity medications as the FDA bans the sale of generic alternatives.
For some time, companies and pharmacies were able to sell cheaper versions of the weight loss drugs Wegovy and Ozempic, thanks to a shortage of semaglutide, a protein that helps control appetite.
Now that the shortage has ended, the FDA has ordered the companies offering these cheaper alternatives to stop. Some will be required to cease production by April 22.
Dr. Laurie Sund, medical director at the Medical Weight Management clinic at MHealth Fairview, joined Minnesota Now host Nina Moini to discuss what this change means for patients.
